Recall of batch No. 1407169 of the product: Xeractan 20 mg
2026-04-16Product Description :
|
الاسم التجاري |
الاسم العلمي |
رقم التسجيل |
رقم التشغيلة المتأثرة |
الشركة الصانعة |
|
Trade Name |
Scientific Name |
Register Number |
Affected batch number |
Manufacturer |
|
Xeractan 20 mg soft gelatin capsule |
Isotretinoin |
2805257489 |
1407169 |
GAP SA PHARMACEUTICAL |
Issue :
The Saudi Food and Drug Authority (SFDA) has issued a recall of batch No. 1407169 of the product Xeractan 20 mg soft gelatin capsules due to out-of-specification results observed during stability studies, which may impact the product’s quality and safety.
Recommendations :
For healthcare professionals: Stop dispensing the batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).